New Transvaginal Mesh Lawsuits Added to C.R. Bard Litigation in Bergen County, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing hundreds of women who allegedly suffered painful and debilitating vaginal mesh complications due to products marketed by C.R. Bard, Inc. and other companies.

Free Case Review
Our Firm is representing numerous women who were allegedly injured by transvaginal mesh manufactured by C.R. Bard Inc.

More than 1,600 C.R. Bard transvaginal mesh lawsuits ( are now pending in a consolidated litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports.

A Case List updated on November 29th shows 1,611 lawsuits now filed in the proceeding, which similarly involves claims against the transvaginal mesh manufacturer, C.R. Bard Inc. Plaintiffs in these cases similarly allege mesh erosion, chronic pain, pain during sexual intercourse, and other complications allegedly caused by the company’s pelvic implants, which are used in the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (SUI). (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

“Our Firm is representing numerous women who were allegedly injured by transvaginal mesh manufactured by C.R. Bard Inc.,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential legal evaluations to women who allegedly sustained organ damage, infection, chronic pain, pain during sexual intercourse and other injuries caused by mesh devices marketed by C.R. Bard Inc., Boston Scientific Corp., American Medical Systems Inc. and the Johnson & Johnson subsidiary, Ethicon.

Transvaginal Mesh Lawsuits

All the transvaginal mesh lawsuits against C.R. Bard in New Jersey were similarly filed after the U.S. Food and Drug Administration (FDA) warned in 2008 that women implanted with the devices may be susceptible to vaginal mesh complications, although the potential was determined to be “rare.” In July 2011, the federal agency determined the risk to be “not rare” after receiving 3,000 adverse event reports from women who were allegedly injured by the devices over a three-year period. In April 2014, the FDA proposed new regulations that would reclassify transvaginal mesh implants as “high risk,” making them subject to greater regulatory oversight.

Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is actively serving as Co-Liaison Counsel for the C.R. Bard mesh litigation in New Jersey’s Bergen County, as well as a separate proceeding involving implants from Johnson & Johnson’s Ethicon unit. For the Ethicon mesh litigation, Mr. Grand served on the plaintiff’s trial team for a case that concluded with an $11 million damage award to a woman who sustained injuries caused by the Gynecare Prolift implant she received. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)

At least 60,000 additional transvaginal mesh lawsuits have also been filed in several federal multidistrict litigations underway in the U.S. District Court, Southern District of West Virginia. Mr. Grand is an active member of the Plaintiffs Steering Committee in the following proceedings: In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2187; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327; Coloplast Corp. Pelvic Support Systems Products Liability Litigation - MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2440; and In Re: Neomedic Pelvic Repair System Products Liability Litigation - MDL No. 2511.

Women who allegedly suffered vaginal mesh complications after receiving implants to repair pelvic organ prolapse or stress urinary incontinence may be eligible to receive compensation for medical bills, lost wages, pain and suffering and other injury-related damages. Learn more about filing a transvaginal mesh lawsuit by visiting Bernstein Liebhard LLP’s website or the Firm’s Facebook page, Free legal reviews can also be obtained by calling 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website